Market reports - Pharma & Biotech
01.04.2012
Global Pharma And Biotech M&A Report 2012 by IMAP
Review of 2011 M&A deals, including Gilead/Pharmasset: anatomy of a billion-dollar R&D deal. And: will Pharma grow in mature markets until 2015? In-depth article: Opportunities and challenges for Big Pharma in China. Download.
27.10.2011
China: Diagnosis for growth - Global Pharma companies face layoffs
After 2006, global Pharma restructured their china businesses. Within just five years, the game has changed again, finds Yu Jingyi of InterChina Consulting (IMAP China) in her report (download here).
25.05.2011
China: The mixed effects of healthcare reform in rural areas
InterChina Consulting (IMAP China) studied the effects of the healthcare reform in rrural areas, and find that some problems were solved, but others emerged. Download here.
